Similar Papers

Paper Title
Journal
Date
Author
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
U.A Matulonis ... B.J Monk
Annals of Oncology | VOL. 28
U.A Matulonis, et. al.U.A Matulonis ... B.J Monk
01 Mar 2017
Discontinuation of poly(adenosine diphosphate-ribose) polymerase inhibitors due to adverse events in patients with recurrent ovarian cancer: A meta-analysis of three phase III trials.
Kyaw Zin Thein ... Myat M Han
Journal of Clinical Oncology | VOL. 36
Kyaw Zin Thein, et. al.Kyaw Zin Thein ... Myat M Han
01 Dec 2018
Inhibited, trapped or adducted: the optimal selective synthetic lethal mix for BRCAness
A Tutt
Annals of Oncology | VOL. 29
A TuttA Tutt
01 Jan 2018
Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review.
Stergios Boussios ... Michele Moschetta
Diagnostics | VOL. 9
Stergios Boussios, et. al.Stergios Boussios ... Michele Moschetta
01 Aug 2019
View more papers

More From: EJC Supplements

Paper Title
Journal
Date
Author
Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?
Martyn E Caplin
EJC Supplements | VOL. 16
Martyn E CaplinMartyn E Caplin
01 Nov 2021
Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
Mohid S Khan ... Marianne E Pavel
EJC Supplements | VOL. 16
Mohid S Khan, et. al.Mohid S Khan ... Marianne E Pavel
01 Nov 2021
Insight updating of the molecular hallmarks in ovarian carcinoma
Alba Mota ... Gema Moreno-Bueno
EJC Supplements | VOL. 15
Alba Mota, et. al.Alba Mota ... Gema Moreno-Bueno
01 Aug 2020
The hallmarks of ovarian cancer: proliferation and cell growth
Raquel López-Reig ... José Antonio López-Guerrero
EJC Supplements | VOL. 15
Raquel López-Reig, et. al.Raquel López-Reig ... José Antonio López-Guerrero
01 Aug 2020
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.